State Street’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

State Street’s Portfolio OCAT Stock Details OCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-545,107	Closed	-$4.59M	–	3778
2015 Q4	$4.59M	Buy	545,107 +134,061	+33%	+$897K	﹤0.01%	2576
2015 Q3	$1.72M	Buy	411,046 +126,620	+45%	+$553K	﹤0.01%	3058
2015 Q2	$1.5M	Buy	+284,426	New	+$1.82M	﹤0.01%	3157

State Street's OCAT Position: Q1 2016 in Review

State Street sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 545,107 shares — an estimated $4.59M sold.

State Street first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $4.59M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

State Street reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
State Street sold 545,107 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $4.59M.
State Street first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
State Street's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $4.59M in Q4 2015.
1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on State Street's 13F filing for Q1 2016, filed 12 May 2016.